You are viewing: Europe AI in Precision Medicine Market analysis

The Europe AI in Precision Medicine Market was valued at $231.02 Million in 2024 and projected to reach to $1185.99 Million by 2029, representing a compound annual growth rate of 31.3%. Europe's AI in Precision Medicine market is poised for exceptional growth, driven by increasing healthcare digitalization, substantial government funding for AI research, and growing adoption among leading medical institutions.

Europe AI in Precision Medicine Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe AI in Precision Medicine Market Trends and Insights

  • This growth trajectory reflects Europe's strong commitment to digital health innovation and regulatory frameworks that support AI adoption in clinical settings.
  • Europe is leveraging advanced machine learning algorithms and data analytics to enhance diagnostic accuracy, treatment personalization, and patient outcomes across oncology, cardiology, and genomics. The European market benefits from substantial healthcare investments, a mature digital infrastructure, and collaborative research ecosystems spanning the EU and UK.
  • Europe's emphasis on data privacy through GDPR and ethical AI governance creates a competitive advantage for precision medicine solutions.
  • Between 2024 and 2029, Europe is expected to consolidate its position as a global leader in AI-driven healthcare innovation, driven by increasing adoption among hospitals, diagnostic centers, and pharmaceutical companies seeking to optimize clinical workflows and reduce healthcare costs..

Key Market Statistics

  • CAGR (2024-2029) 31.3% CAGR
  • Market Size, 2024 ~USD 231.02 Million
  • Forecast, 2029 ~USD 1185.99 Million
  • Geography Europe

Europe AI in Precision Medicine Market Overview

Market Valuation & Growth :

Europe's AI in Precision Medicine market is valued at $231.02 million in 2024, with a robust CAGR of 31.3% projected through 2029, reaching $1,185.99 million. This growth significantly outpaces many other regions, driven by substantial healthcare investments and digital transformation initiatives across European nations.

Regulatory Support & Innovation :

Europe's comprehensive regulatory frameworks, including GDPR and MDR compliance standards, create a trusted environment for AI adoption in clinical settings. These regulations, while stringent, foster innovation and ensure patient safety, positioning Europe as a leader in responsible AI implementation within precision medicine.

Advanced Technology Integration :

European healthcare systems are rapidly integrating machine learning algorithms and advanced data analytics into diagnostic and treatment protocols. This technological adoption enables personalized medicine approaches, improving patient outcomes and operational efficiency across hospitals and research institutions.

Strong Healthcare Infrastructure :

Europe's well-established healthcare infrastructure, combined with significant R&D investments and collaborative research networks, accelerates AI precision medicine adoption. Leading pharmaceutical companies and biotech firms are establishing innovation hubs across major European markets to capitalize on this growth opportunity.

Europe AI in Precision Medicine Market Dynamics

  • The region's commitment to data privacy and ethical AI development creates competitive advantages, attracting global investment and talent.
  • European healthcare providers are increasingly deploying AI-powered diagnostic tools, genomic analysis platforms, and personalized treatment planning systems to enhance clinical outcomes and reduce healthcare costs. Looking ahead to 2029, Europe will likely emerge as a global benchmark for responsible AI implementation in precision medicine.
  • Continued collaboration between healthcare systems, technology providers, and regulatory bodies will facilitate seamless integration of AI solutions.
  • The market expansion will be supported by increasing reimbursement policies for AI-driven diagnostics, growing patient awareness, and expanding applications across oncology, cardiology, and rare disease management, positioning Europe as a key driver of global precision medicine innovation..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Danaher Corporation

    Analytical And Scientific Instrumentation

    Top Technologies
    • Environmental Testing
    • Gas Chromatography
    • Polymerase Chain Reaction (PCR)
    • Automated Liquid Handling Systems
    • Flow Cytometry
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Shimadzu Corporation
    • Merck KGaA

      Healthcare Analytics

      Top Technologies
      • Machine Learning
      • Natural Language Processing (NLP)
      • Blood Pressure Monitors
      • Computed Tomography (CT)
      • Magnetic Resonance Imaging (MRI)
      Top Companies
      • Oracle Corporation
      • PHILIPS HEALTHCARE
      • Siemens healthineers
      • Zensar Technologies Limited
      • EPIC SYSTEMS CORPORATION

        Key Takeaways

        • Europe's AI in Precision Medicine market will grow from $231.02M (2024) to $1,185.99M (2029), representing a 31.3% CAGR.
        • Europe leads in regulatory-compliant AI adoption, with GDPR and ethical frameworks driving trusted implementation across healthcare systems.
        • Europe's market expansion is fueled by strong R&D investments, collaborative academic-industry partnerships, and digital health infrastructure maturity.
        • Europe's precision medicine solutions are increasingly deployed in oncology, cardiology, and genomics, improving diagnostic accuracy and treatment personalization.

        AI in Precision Medicine Market Report Scope

        Report Metric Details
        Base Year 2024
        Fastest Growing Segment IMAGE ANALYSIS (Tool)
        Forecast Period 2024-2029
        Growth Rate CAGR of 30.7% from 2024 to 2029
        Largest Segment SOFTWARE (Component)
        Market Size Base Year (Billions) ~USD 0.79 (2024)
        Revenue Forecast (Billions) ~USD 3.92 (2029)
        Segments Covered Application, Type, Therapeutic Area, Component, Tool, Deployment, End User, Deployment 2022-2030

        Europe AI in Precision Medicine Market Report Segmentation

        8 segment dimensions are covered across the global market.

        By Application

        • Clinical Development
        • De Novo Drug Design
        • Diagnostic & Screening
        • Diagnostics & Screening
        • Drug Discovery
        • Drug Discovery & Development
        • Drug Optimization
        • Drug Repurposing
        • Safety
        • Therapeutics
        • Understanding Diseases

        By Type

        • Deep Learning
        • Disease Diagnosis
        • Disease Progression, Staging & Prognosis
        • Disease Screening
        • Other Machine Learning Types
        • Post Treatment Surveillance & Follow-Up
        • Reinforcement Learning
        • Risk Assessment & Patient Stratification
        • Supervised Learning
        • Therapy Monitoring
        • Therapy Selection & Planning
        • Unsupervised Learning

        By Therapeutic Area

        • Cardiology
        • Hematology
        • Infectious Diseases
        • Neurology
        • Oncology
        • Other Therapeutic Area
        • Other Therapeutic Areas
        • Rare Disease
        • Rare Diseases

        By Component

        • Services
        • Software

        By Tool

        • Computer Vision
        • Context Aware Processing
        • Context-Aware Processing
        • Context-Aware Processing & Computing
        • Image Analysis
        • Machine Learning
        • Natural Language Processing
        • Nlp
        • Other Tools

        By Deployment

        • Cloud-Based
        • Cloud-Based Model
        • Hybrid
        • Hybrid Model
        • On-Premise
        • On-Premise Model

        By End User

        • Healthcare Providers
        • Medical Device/Equipment Companies
        • Other End Users
        • Pharmaceutical & Biotechnology Companies
        • Research Centers, Academic Institutes & Government Organizations
        • Research Centers, Academic Institutes, & Government Organizations

        By Deployment 2022-2030

        • Cloud Based
        • Cloud-Based
        • Hybrid
        • On-Premise

        REST OF EUROPE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030

        Segment202220232024202520262027202820292030CAGR (%)
        HEALTHCARE PROVIDERS7.5610.0513.3417.7223.5131.1941.3654.8372.6432.6
        MEDICAL DEVICE/EQUIPMENT COMPANIES4.926.58.5911.3514.9819.7826.134.4245.3832
        OTHER END USERS1.632.132.793.654.776.238.1410.6413.8930.7
        PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES6.16810.3913.4917.522.6929.4238.1349.429.7
        RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS4.145.346.888.8611.414.6718.8624.2531.1628.6
        TOTAL24.4132.0241.9955.0572.1694.56123.89162.26212.4731

        EUROPE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030

        Segment202220232024202520262027202820292030CAGR (%)
        HEALTHCARE PROVIDERS42.2756.274.6999.23131.79174.97232.23308.13408.732.7
        MEDICAL DEVICE/EQUIPMENT COMPANIES27.2536.1147.8263.3183.8110.86146.63193.86256.2232.3
        OTHER END USERS11.7915.4820.3326.683545.9160.1978.88103.3531.1
        PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES33.3343.3956.4773.4795.55124.21161.42209.71272.3430
        RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS19.0324.5731.7140.9152.7668.0187.64112.89145.3828.9
        TOTAL133.67175.75231.02303.6398.88523.96688.1903.471185.9931.3

        Target Audience

        • Healthcare Technology Providers : AI software vendors and digital health companies need detailed European market insights to develop localized solutions, navigate regulatory requirements, and identify partnership opportunities with healthcare providers and research institutions.
        • Pharmaceutical & Biotech Companies : Drug developers and biotech firms require market intelligence to integrate AI-powered precision medicine into their R&D pipelines, identify acquisition targets, and establish collaborations with European research centers and clinical networks.
        • Healthcare Investors & PE Firms : Investment professionals need comprehensive market data to identify high-growth opportunities, evaluate portfolio companies, and assess the European precision medicine landscape for strategic acquisitions and funding decisions.
        • Hospital & Clinical Networks : Healthcare providers and hospital systems need market insights to evaluate AI solution vendors, understand implementation best practices, benchmark against peers, and develop digital transformation strategies aligned with precision medicine initiatives.
        • Government & Policy Makers : Healthcare regulators and government agencies require market analysis to inform policy development, funding allocation, and strategic initiatives supporting AI adoption in precision medicine while ensuring patient safety and data protection.

        Europe vs. other regions

        HowEurope compares to the other 3 regional blocs covered in this market.

        North America
        ~USD 1718.22 Million · 31.9% wtd CAGR ·
        Asia Pacific
        ~USD 776.17 Million · 27.9% wtd CAGR ·
        Latin America
        ~USD 147.86 Million · 30.1% wtd CAGR ·
        Middle East & Africa
        ~USD 95.36 Million · 28.1% wtd CAGR ·

        Countries within Europe - compare and drill down

        Country2025 size (native)
        UKUSD 17.54 Million
        GermanyUSD 16.24 Million
        FranceUSD 10.42 Million
        ItalyUSD 6.34 Million
        SpainUSD 4.87 Million
        Rest Of EuropeUSD 212.47 Million

        Country market size visualization

        UK
        USD 17.54 Million
        Germany
        USD 16.24 Million
        France
        USD 10.42 Million
        Italy
        USD 6.34 Million
        Spain
        USD 4.87 Million
        Rest Of Europe
        USD 212.47 Million

        Reasons to Buy this Report

        • Market Size & Growth Projections : Gain detailed insights into Europe's $231.02M market expanding to $1,185.99M by 2029 at 31.3% CAGR. Understand country-level breakdowns and identify high-growth segments within the European precision medicine landscape.
        • Regulatory & Compliance Landscape : Navigate Europe's complex regulatory environment including GDPR, MDR, and CE marking requirements. Our analysis provides actionable guidance on compliance strategies and how regulations shape market opportunities across different European markets.
        • Competitive Intelligence : Identify leading European and international players in AI precision medicine, their market positioning, and strategic initiatives. Understand competitive dynamics, partnerships, and innovation strategies to inform your market entry or expansion plans.
        • Country-Specific Opportunities : Analyze individual European markets including UK, Germany, France, Italy, and Spain with tailored insights on healthcare spending, adoption rates, and growth drivers. Prioritize markets based on your business objectives and resource allocation.
        • Strategic Decision Support : Leverage comprehensive market data to support investment decisions, partnership evaluations, and product development strategies. Make informed decisions on market entry timing, geographic prioritization, and resource allocation across European regions.

        Frequently asked questions

        What is the current market size of AI in Precision Medicine in Europe?

        Europe's AI in Precision Medicine market was valued at $231.02 million in 2024 and is projected to reach $1,185.99 million by 2029.

        What is the expected growth rate for Europe's AI in Precision Medicine market?

        Europe's market is expected to grow at a compound annual growth rate (CAGR) of 31.3% from 2024 to 2029.

        Which therapeutic areas are driving AI adoption in Europe's precision medicine sector?

        Europe's precision medicine market is primarily driven by AI applications in oncology, cardiology, and genomics, where diagnostic accuracy and treatment personalization are critical.

        How does Europe's regulatory environment support AI in Precision Medicine?

        Europe's GDPR compliance requirements and ethical AI governance frameworks create a trusted environment for precision medicine innovation while ensuring data privacy and responsible AI deployment.

        What factors are accelerating AI adoption in European healthcare systems?

        Europe's market growth is driven by substantial healthcare investments, mature digital infrastructure, collaborative research ecosystems, and increasing demand from hospitals and diagnostic centers to optimize clinical workflows.

        RESEARCH METHODOLOGY

        The study involved significant activities to estimate the current size of the AI in precision medicine market. Exhaustive secondary research was done to collect information on the AI in precision medicine market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the AI in precision medicine market.

        Secondary Research

        This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for the companies offering AI in precision medicine solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases.

        Various secondary sources were referred to in the secondary research process to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of AI in precision medicine vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

        Primary Research

        In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the AI in precision medicine market.

        After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also undertaken to identify the segmentation types, industry trends, competitive landscape of AI in precision medicine solutions offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies.

        In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

        Breakdown of Primary Participants:

        AI in Precision Medicine Market

        Note 1: Others include sales managers, marketing managers, and product managers.

        Note 2: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

        To know about the assumptions considered for the study, download the pdf brochure

        Market Size Estimation

        Both top-down and bottom-up approaches were used to estimate and validate the total size of the AI in precision medicine market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

        • The key players in the industry and markets have been identified through extensive secondary research.
        • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
        • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
        AI in Precision Medicine Market

        Data Triangulation

        After arriving at the overall market size using the market size estimation processes explained above, the market was split into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

        Market Definition

        The AI in precision medicine market utilises AI technologies such as machine learning and natural language processing to analyse complicated biological and clinical data in order to provide possibly personalised healthcare solutions. It promotes applications such as drug discovery, diagnostics, predictive analytics, and tailored treatment plans by integrating genomics, proteomics, and real-world data using AI capabilities with the goal of improving patient outcomes and accelerating innovation benefits for stakeholders ranging from pharmaceutical companies and healthcare providers to researchers.

        Stakeholders

        • Transfection products manufacturing companies
        • Pharmaceutical & Biopharmaceutical Companies
        • Chemical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations (CROs)
        • Contract Development and Manufacturing Organizations (CDMOs)
        • Research Institutes and Universities 
        • Venture Capitalists & Investors
        • Government Associations

        Report Objectives

        • To define, describe, and forecast the AI in precision medicine market based on application, therapeutic area, component, tools, deployment, end user, and region.
        • To provide detailed information about the major factors (drivers, opportunities, restraints, and challenges) influencing the growth of the market
        • To analyze opportunities for stakeholders by identifying the high-growth segments of the market
        • To forecast the size of the market segments with respect to five main regions: North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
        • To analyze subsegments of the market with respect to individual growth trends, prospects, and contributions to the overall market
        • To profile the key players and comprehensively analyze their market sizes and core competencies.
        • To track and analyze competitive developments such as acquisitions, collaborations, agreements, mergers, product launches & updates, partnerships, expansions, and other recent developments in the market globally.

        Get the Full AI in Precision Medicine Market Report

        Full forecast, segment splits, and company analysis for all AI in Precision Medicine Market.

        Need a Tailored Report?

        Customize this report to your needs

        Get 10% FREE Customization

        Customize This Report
        Fact checked
        DMCA.com Protection Status